Monocytes and macrophages: emerging mechanisms and novel therapeutic targets in pulmonary fibrosisCarole Y. Perrot, Jose D. Herazo‐Maya, Τheodoros Karampitsakos|American Journal of Physiology-Cell Physiology|2023Cited by 82
Convergent and divergent immune aberrations in COVID-19, post-COVID-19-interstitial lung disease, and idiopathic pulmonary fibrosisBochra Tourki, Jose D. Herazo‐Maya, Kami Kim et al.|American Journal of Physiology-Cell Physiology|2024Cited by 9
The transcriptome of CD14 <sup>+</sup> CD163 <sup>-</sup> HLA-DR <sup>low</sup> monocytes predicts mortality in Idiopathic Pulmonary FibrosisΤheodoros Karampitsakos, Jose D. Herazo‐Maya, Bochra Tourki et al.|medRxiv|2024Cited by 3
The transcriptome of CD14 <sup>+</sup> CD163 <sup>−</sup> HLA-DR <sup>low</sup> monocytes predicts mortality in idiopathic pulmonary fibrosisΤheodoros Karampitsakos, Jose D. Herazo‐Maya, Minxue Jia et al.|European Respiratory Journal|2025Cited by 2
The transcriptome of CD14+CD163-HLA-DRlow monocytes predicts mortality in Idiopathic Pulmonary FibrosisΤheodoros Karampitsakos, Jose D. Herazo‐Maya, Minxue Jia et al.|Unknown|2025Cited by 2